Table 5a.
Baseline and Follow up of T2D patients with EPN
| Parameter | UTI at baseline n=20 | UTI at follow up n=20 | P * |
|---|---|---|---|
| FBG (mg/dl) | 294±94 | 209±49 | <0.001 |
| Blood glucose PP | 345±77 | 269±58 | <0.001 |
| HbA1c in % | 12.0±2.2 | 9.1±1.4 | <0.001 |
| Creatinine (mg/dl) | 2.2±1.0 | 1.5±1.0 | 0.039 |
| eGFR (ml/min/1.73m2) | 28.6±12.1 | 51.8±20.2 | <0.001 |
| Proteinuria | 12 (60) | 4 (20) | 0.011 |
| Bacteriuria | 18 (90) | 4 (20) | <0.001 |
| Pyuria | 19 (95) | 4 (20) | <0.001 |
| Glycosuria | 19 (95) | 7 (35) | <0.001 |
| Organism | |||
| E. coli | 16 (80) | 4 (20) | |
| Other | 2 (10) | 0 (0) |
Categorical variables [n (%)] and Continuous variables [mean±SD]. *P<0.05 is considered statistically significant. FBG-fasting blood glucose, PP-post prandial, HbA1c-glycosylated hemoglobin, eGFR-estimated glomerular filtration rate